Severe Eosinophilic Asthma Phenotypes During Childhood Have Various Origins
NCT05762627 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 360
Last updated 2023-03-09
Summary
Study of the clinical evolution at 10 years of children from the SAMP cohort (severe asthma, eosinophilic or not, allergic or not) in order to understand the different possible evolutions of these phenotypes at different ages.
Conditions
- Severe Asthma
- Asthma in Children
Sponsors & Collaborators
-
Assistance Publique - Hôpitaux de Paris
lead OTHER
Principal Investigators
-
Mélisande Bourgoin-Heck, MD, MSc · Assistance Publique - Hôpitaux de Paris
Eligibility
- Min Age
- 6 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-03-31
- Primary Completion
- 2026-03-31
- Completion
- 2027-03-31
Countries
- France
Study Locations
More Related Trials
-
Epidemiology of Symptom Perception in Childhood Asthma
NCT00005461 ·Status: COMPLETED
-
Cohort Analysis of Clinical and Biological Severe Childhood Asthma
NCT02114034 ·Status: ACTIVE_NOT_RECRUITING
-
Observational and Epidemiologic Study of the Disease Course and Unmet Needs in Children With Symptomatic Moderate to Severe Allergic Asthma
NCT01362621 ·Status: COMPLETED
-
Safety and Efficacy of SA09012 in Asthma
NCT01740986 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of 2 Doses of MAP0010 and Placebo in Asthmatic Children
NCT00569192 ·Status: COMPLETED ·Phase: PHASE3
-
Longitudinal Assessment of Children With Severe Asthma and Severe Pre-school Wheeze
NCT01982162 ·Status: COMPLETED
-
Phenotypic and Functional Characterization of Neutrophils and Eosinophils in Severe Asthma Treated With Biotherapy
NCT05972213 ·Status: RECRUITING
-
Research on Severe Asthma
NCT04077528 ·Status: RECRUITING
-
Effects of Anti-IL5 Biological Treatments on Blood IgE Levels in Severe Asthmatic Patients
NCT04181190 ·Status: COMPLETED
-
Severe Asthma, MepolizumaB and Affect: SAMBA Study
NCT04680611 ·Status: RECRUITING
-
A Study of MK0476 in the Treatment of Asthma Patients Aged 2-5 Years (0476-907)
NCT00700661 ·Status: COMPLETED ·Phase: PHASE3
-
Persistence of Airway Inflammation and Remodeling in Subjects With Symptomatic or Complete Asthma Remission
NCT00526019 ·Status: COMPLETED
-
Characterisation of Patients With Severe Asthma in Primary and Secondary Care Settings in Europe Reported to be Eligible for Biological Therapy
NCT03629782 ·Status: COMPLETED
-
An Observational, Retrospective Multicentre Medical Record Review to Describe the Post-authorisation Early Clinical Experience of Dupilumab in the Treatment of Adult Severe Asthma
NCT06064526 ·Status: COMPLETED
-
Dupilumab Efficacy on Bronchial Inflammation, Small Airways Disfunction and Mucous Secretion
NCT05787678 ·Status: RECRUITING
-
Spirometry and Methacholine Challenge Test in Asthmatic Children Age 3-6years
NCT00550758 ·Status: TERMINATED ·Phase: NA
-
National Validation and Sensitivity to Change of the SAQ
NCT04031261 ·Status: COMPLETED
-
A Study in Male and Female Adolescent Participants With Severe Uncontrolled Asthma Starting Treatment With Dupilumab Injection (Dupixent®)
NCT05070663 ·Status: COMPLETED
-
Pharmacokinetics and Pharmacodynamics, Efficacy and Safety of Omalizumab in Japanese Children (6 - 15 Years)
NCT01155700 ·Status: COMPLETED ·Phase: PHASE3
-
Changes in Gene Transcription and Immunophenotypes Following Mepolizumab Treatment for Asthma
NCT05002621 ·Status: COMPLETED
-
Comparative Study of the Efficacy of Biologics vs Usual Treatment on OCS Reduction for Severe Asthma Patients Using Health Insurance Claim Database
NCT05136547 ·Status: COMPLETED
-
Study to Evaluate the Effect of Omalizumab on Improving the Tolerability of Specific Immunotherapy in Patients With Persistent Allergic Asthma
NCT00267202 ·Status: COMPLETED ·Phase: PHASE4
-
Homeostatic Roles of Eosinophils in Asthma
NCT06676397 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
A Study of CM310 in Subjects With Moderate to Severe Asthma
NCT05761028 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
A Cohort Study of Risk Factors and Prognosis for Frequent Acute Asthma Exacerbations Phenotype
NCT06621056 ·Status: RECRUITING